Vimal Mehta
2020
In 2020, Vimal Mehta earned a total compensation of $9.6M as Chief Executive Officer and President at BioXcel Therapeutics, a 386% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $556,250 |
|---|---|
| Option Awards | $8,122,500 |
| Salary | $890,000 |
| Other | $7,800 |
| Total | $9,576,550 |
Mehta received $8.1M in option awards, accounting for 85% of the total pay in 2020.
Mehta also received $556.3K in non-equity incentive plan, $890K in salary and $7.8K in other compensation.
Rankings
In 2020, Vimal Mehta's compensation ranked 879th out of 13,090 executives tracked by ExecPay. In other words, Mehta earned more than 93.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 879 out of 13,090 | 93rd |
Division Manufacturing | 310 out of 5,621 | 95th |
Major group Chemicals And Allied Products | 98 out of 2,254 | 96th |
Industry group Drugs | 85 out of 1,954 | 96th |
Industry Pharmaceutical Preparations | 65 out of 1,459 | 96th |
Source: SEC filing on April 27, 2021.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2020.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019